Cite
HARVARD Citation
Hobart, M. et al. (2019). A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder. Journal of clinical psychopharmacology. 39 (3), p. . [Online].